Eupraxia Pharmaceuticals Inc. Alternatives & Competitors

12 companies similar to Eupraxia Pharmaceuticals Inc. — Developing Precision Therapies

KBP Biosciences

At KBP we are consistently reminded that patient care is the end goal of what we do daily.

40 Series A $76.00M

Princeton, United States

Biotechnology Health Care +1

Visterra Inc.

We bring better biologics to life. Biospace Best Place to Work 2024!

139 Series C $125.39M

Waltham, United States

Biotechnology Health Care +1

Asieris Pharmaceuticals

We strive for healthy and dignified lives!

60 Series D $1.19B

United States

Biotechnology Health Care +1

PaxMedica, Inc.

Empowering Possibilities, Transforming Lives: PaxMedica's Journey in Neurodevelopmental So...

7 Post-IPO Equity $30.68M

Tarrytown, United States

Biotechnology Pharmaceutical

Track all Eupraxia Pharmaceuticals Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Realm Therapeutics, Inc.

2 Post-IPO Equity $26.00M

Malvern, United States

Biotechnology Pharmaceutical

Reistone Biopharma

Focusing on rapidly developing innovative medicines through global collaborations within R...

52 Series A $100.00M

China

Biotechnology Pharmaceutical

CytoAgents, Inc

Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for mult...

10 Series A $22.60M

Pittsburgh, United States

Biotechnology Health Care +1

Gate Neurosciences

Brain Health, Reimagined

15 Venture round $41.10M

Indianapolis, United Stat...

Biotechnology Health Care +2

Ampio Pharmaceuticals, Inc.

7 Post-IPO Equity $75.89M

Englewood, United States

Biotechnology Health Care

Gossamer Bio

Vision * Connection * Innovation

159 Post-IPO Equity $812.00M

San Diego, United States

Biotechnology Health Care +1

Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clini...

Series A $142.00M

Biopharma Biotechnology +1

Pinteon Therapeutics

Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...

2-10 Series B $51.60M

Biotechnology Health Care +1

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc. Slogan: Developing Precision Therapies Description: Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs. Each of Eupraxia's product candidates has the potential to address therapeutic...

Taxonomy

Clinical-stage, Drug Development, Precision Therapies, Extended-release Formulations, Therapeutic Areas, Unmet Medical Needs, Patient Benefit, Long-acting Formulations, Post-surgical Pain, Infections, Tolerability, Osteoarthritis, Veterinary Medicine, Animal Health

Frequently Asked Questions

Companies similar to Eupraxia Pharmaceuticals Inc. include KBP Biosciences, Visterra Inc., Asieris Pharmaceuticals, PaxMedica, Inc., Realm Therapeutics, Inc.. They work in Biotechnology and Health Care and share Eupraxia Pharmaceuticals Inc.'s focus on drug development, unmet medical needs and clinical-stage.

Bounce Watch lists 12 companies that share Eupraxia Pharmaceuticals Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Eupraxia Pharmaceuticals Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Eupraxia Pharmaceuticals Inc. Profile KBP Biosciences Alternatives Visterra Inc. Alternatives Asieris Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Eupraxia Pharmaceuticals Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.